Official Title
Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
Brief Summary

The goal of this study is to study the correlation of maternal and cord blood level ofAnti SAR-CoV.

Detailed Description

The goal of this study is to study the correlation of maternal and cord blood level of
Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in
October - November 2023, who have at least one COVID-19 vaccination before or when
pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and
effect of vaccine type on Antibody level.

Completed
COVID-19

Diagnostic Test: COVID-19 Spike Protein IgG Quantitative Antibody (CMIA)

Maternal blood and cord blood were collected to test for COVID-19 Spike Protein IgG
Quantitative Antibody (CMIA)

Eligibility Criteria

Inclusion Criteria:

- Thai term pregnant women

- 18-45 year old

- At least 1 covid vaccination received

- admission at Vachira Phuket Hospital Labor Room

Exclusion Criteria:

- Do not want to participate

- Unstable or Emergency condition

Eligibility Gender
Female
Eligibility Age
Minimum: 18 Years ~ Maximum: 45 Years
Countries
Thailand
Locations

Vachira Phuket Hospital
Phuket 1151254, Thailand

Not Provided

Vachira Phuket Hospital
NCT Number
Keywords
Anti SARs-CoV
pregnancy
Cordblood
Vaccine
MeSH Terms
COVID-19